Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
about
New Perspectives in the Treatment of Colorectal MetastasesLocal Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumorsImpact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases.Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study.Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence.Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection.Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization.Image-Guided Thermal Ablative Therapies in the Treatment of Sarcoma.Adjuvant Medications That Improve Survival after Locoregional Therapy.Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.Immediate Post-ablation FDG-injection and corresponding Standardized Uptake Value is a Surrogate Biomarker of Local Tumor Progression after Thermal Ablation of Colorectal Carcinoma Liver Metastases.Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy.Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : New advances in interventional oncology: state of the art.Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy.Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone.Imaging performance and clinical value of contrast-enhanced ultrasonography and computed tomography in the diagnosis of liver cancer.Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer.Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources.Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration
P2860
Q28073788-C7C627D8-0C42-4FE7-A107-2F2CE2695453Q33614301-7622EE96-2C03-46D1-9667-5F5BDEB2DC0CQ33695043-F48DEDE4-EE4C-473C-9957-F1D3E112E744Q37231438-749E1C57-6AA5-466A-8320-445BE07C77FDQ37427913-6A123834-E1BE-4BB1-8631-F4C7C10DBA09Q38671021-DCD4971A-A61E-4BDC-AF38-025E8CE27031Q38726773-F515BD4F-7ED6-43C8-BF6C-C6A5FC7D69C7Q38755742-5AD18087-0E31-494A-8A7D-8E5D8E444A0EQ38787064-2D0D0099-036C-48AE-8B27-4A3DC98DA368Q38791333-FD2B5292-D01C-4C45-93F9-5DA5A9861368Q38830196-C9CD8A32-42B7-415C-8272-965F12BE5E7EQ38888162-D5CD2D3A-1D33-4C9F-8ABD-F2825174CE0CQ38903862-9B745511-278A-4D51-8DC2-61C9D089E082Q39229412-F62FBF81-A66D-4B3B-B965-E3E62119D1C5Q39319921-3542C35A-F0BF-41F5-9D94-472970A8EB51Q39815313-1F3FEC5E-D19A-4297-A1F7-1183AC882789Q40317208-DB4EF06C-33F2-40D2-88EF-82A4CED73CADQ40510233-C04F12AE-5AAA-4693-BC98-81930DD22800Q40898512-4211B7EE-207D-4801-8A53-F4DA5324D464Q42371613-A650D0FC-0571-4B5D-9482-2415187AC5A7Q47093792-EAB96CDC-EC4B-45A2-B3B8-12DAC5818CF3Q48301301-39057F56-8610-442C-8E06-2CBACB5A9FA9Q50036604-A14A27BC-EDE5-4E99-80A8-048B72620E66Q50066860-73D06957-11AC-465D-AF75-122A360B4792Q50083772-FE841CC3-5E29-466F-B926-9C21BED1E4BDQ50324017-F141144D-70EA-48E2-9A1F-4ADC96BBD756Q50881709-60DAF782-BBDA-47A2-A255-9353B4B2EB0AQ51818890-897A5239-9D0F-4F07-BDCB-7846ED89C320Q52770098-DBD2A3AA-D537-45A9-B992-895E94C7F8B3Q53000448-19CB90B9-7161-4771-B8A2-FCA127E2C453Q53597390-C4CA99FB-F37F-425E-BCBE-1AFDC97BDD8FQ53723381-36485E88-5377-4D20-B6E2-90144330816DQ54945895-C751023C-13DB-437B-A018-9F707BBB1455Q55144990-3B39A344-FED9-4E05-8307-FEACD0382C1AQ55349038-A3F0192B-7A40-458A-BD42-F3F6AE201567Q58565410-5A3B722E-E082-4408-95F7-EC276363DAE2
P2860
Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Percutaneous Radiofrequency Ab ...... Experience at a Single Center.
@ast
Percutaneous Radiofrequency Ab ...... Experience at a Single Center.
@en
type
label
Percutaneous Radiofrequency Ab ...... Experience at a Single Center.
@ast
Percutaneous Radiofrequency Ab ...... Experience at a Single Center.
@en
prefLabel
Percutaneous Radiofrequency Ab ...... Experience at a Single Center.
@ast
Percutaneous Radiofrequency Ab ...... Experience at a Single Center.
@en
P2093
P2860
P1433
P1476
Percutaneous Radiofrequency Ab ...... Experience at a Single Center.
@en
P2093
Anne M Covey
Constantinos T Sofocleous
Elena N Petre
Joseph P Erinjeri
Karen T Brown
Lynn A Brody
Michael I D'Angelica
Mithat Gonen
Nancy E Kemeny
Robert H Siegelbaum
P2860
P304
P356
10.1148/RADIOL.2015142489
P407
P577
2015-08-12T00:00:00Z